ClinicalTrials.gg
RecruitingNCT07542106Updated Apr 21, 2026

Effectiveness of a Visual Biofeedback Program Versus Conventional Physiotherapy on Shoulder Mobility, Strength, and Function in Women After Breast Cancer Surgery

An interventional study of Experimental Group: Physiotherapy + Visual Biofeedback in Breast Cancer and Shoulder Dysfunction, sponsored by University of Extremadura. Recruiting at 1 site in Spain. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by University of Extremadura · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study aims to evaluate the effectiveness of a physiotherapy program incorporating visual biofeedback compared to a conventional physiotherapy program in improving shoulder function in women following breast cancer surgery.

Breast cancer survivors frequently experience shoulder dysfunction, including reduced range of motion, decreased strength, altered neuromuscular activity, and impaired scapulohumeral control. While conventional physiotherapy is effective, there is growing interest in interventions targeting motor control and neuromuscular coordination through biofeedback strategies.

Participants will be randomly assigned to either a control group receiving conventional physiotherapy or an experimental group receiving the same program supplemented with visual biofeedback using the MotionGuidance system. Outcomes will include shoulder strength, range of motion, functional performance, electromyographic activity, and muscle oxygen saturation.

Read the detailed description

Breast cancer is the most common malignancy among women worldwide, with increasing survival rates. However, many survivors experience long-term musculoskeletal complications, particularly affecting the shoulder complex. These include reduced mobility, altered neuromuscular activation, scapular dyskinesis, and functional limitations.

Conventional physiotherapy interventions focusing on mobility, strengthening, and motor control are widely used and supported by evidence. However, there is considerable heterogeneity in treatment protocols and limited research exploring neuromuscular adaptations using objective measures such as electromyography (EMG) and near-infrared spectroscopy (NIRS).

Visual biofeedback interventions, such as MotionGuidance, may enhance motor learning, movement accuracy, and adherence by providing real-time external feedback. Despite their potential, few clinical trials have compared biofeedback-based rehabilitation with standard physiotherapy in breast cancer populations.

This randomized controlled trial will compare two interventions over 8 weeks: (1) conventional physiotherapy and (2) conventional physiotherapy combined with visual biofeedback. Both groups will receive identical treatment dosage, differing only in the use of biofeedback.

The study also incorporates objective neuromuscular and metabolic assessments, including EMG and muscle oxygen saturation (SmO₂), to better understand the mechanisms underlying rehabilitation outcomes.

02

Conditions studied

  • Breast Cancer
  • Shoulder Dysfunction

Browse trials for

Keywords

  • Breast Cancer Rehabilitation
  • Shoulder Dysfunction
  • Physiotherapy
  • Biofeedback
  • Motion Control
  • Electromyography
  • Muscle Oxygenation
03

In context

Breast Neoplasms

14,825 studies on the registry are indexed under Breast Neoplasms; 3,319 are open to participants now.

This study's planned enrollment of 40 is below the median of 72 across 10,896 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

University of Extremadura is the lead sponsor of 48 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18 years or older
  • History of breast cancer surgery (mastectomy or breast-conserving surgery within the last 6 months)
  • Presence of shoulder pain, reduced range of motion, strength deficit, or functional limitation
  • Ability to understand and follow study instructions

Exclusion criteria

Exclusion Criteria:

  • Presence of
  • Post-surgical complications contraindicating exercise
  • Severe lymphedema (Stage III or IV)
  • Neurological disorders affecting the upper limb
  • Severe musculoskeletal shoulder conditions unrelated to breast cancer
  • Participation in other rehabilitation programs
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Experimental Group: Physiotherapy + Visual Biofeedback

    Participants will receive a structured physiotherapy program combined with visual biofeedback using the MotionGuidance system. The intervention includes guided exercises with laser-based visual feedback to improve motor control and movement accuracy.

    Procedure: Experimental Group: Physiotherapy + Visual Biofeedback

  • No intervention
    Control Group: Conventional Physiotherapy

    Participants will receive a standard physiotherapy program focused on mobility, strengthening, and motor control of the shoulder without biofeedback.

Interventions

  • ProcedureExperimental Group: Physiotherapy + Visual Biofeedback

    Participants will receive a structured physiotherapy program combined with visual biofeedback using the MotionGuidance system. The intervention includes guided exercises with laser-based visual feedback to improve motor control and movement accuracy.

06

What researchers measure

Primary outcomes

  1. Shoulder Strength (kg)

    Measured using handheld dynamometry (isometric strength in flexion, abduction, and external rotation).

    Time frame: Baseline and 8 weeks

Secondary outcomes

  1. Range of Motion (degrees)

    Measured using goniometry (flexion, abduction, internal and external rotation).

    Time frame: Baseline and 8 weeks

  2. Muscle Activity (EMG-microvolts)

    Surface electromyography analysis (RMS-Root mean square, and activation timing of shoulder muscles)

    Time frame: Baseline and 8 weeks

  3. Muscle Oxygen Saturation (SmO₂)

    Measured using near-infrared spectroscopy (Moxy Monitor).

    Time frame: Baseline and 8 weeks

  4. Handgrip Strength (kg)

    Measured using a digital dynamometer.

    Time frame: Baseline and 8 weeks

  5. Functional Performance (Sit-to-Stand Test)

    Time required to complete the test.

    Time frame: Baseline and 8 weeks

  6. Fatigue (Piper Fatigue Scale)

    The Piper Fatigue Scale (PFS) (revised) is scored by calculating averages on a numerical scale of 0 to 10 to measure the intensity and impact of fatigue on patients. Higher scores indicate higher levels of fatigue.

    Time frame: Baseline and 8 weeks

  7. Quality of Life (SF-36 Questionnaire)

    The SF-36 questionnaire measures health-related quality of life in eight dimensions, where higher scores (0-100) indicate better health. It evaluates physical functioning, pain, general health, vitality, social functioning and mental health.

    Time frame: Baseline and 8 weeks

07

Study locations

1 of 1 sites recruiting
  • Facultad de Mecina y Ciencias de la Salud
    Badajoz, Badajoz 06006, Spain
    Recruiting
    • Mª Dolores MD Apolo-Arenas, PhD · Contactmdapolo@unex.es · 924489180
    • Alejandro ACP Caña-Pino, PhD · Principal investigator
    • Carmen CCG Cabanillas García de la Trenada · Principal investigator
    • Cesar Luís CDM Díaz Muñoz, Phd · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07542106
Lead sponsor
University of Extremadura
Responsible party
Alejandro Caña Pino (Investigator, University of Extremadura) — Principal investigator
First posted
Apr 21, 2026
Start date
Apr 14, 2026
Primary completion
Apr 14, 2026
Completion
May 15, 2026 (estimated)
Last update
Apr 21, 2026

Study contacts

Mª Dolores MDAA Apolo-Arenas, PhD
Contact
mdapolo@unex.es
924489180

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion